Sorry, you need to enable JavaScript to visit this website.

Categories

Keywords

  • All Keywords
September 2022
August 2022

Press Kits

These downloadable files, including fact sheets about Pfizer and approved images or videos, are packages curated by the Global Media Relations team for use by professional journalists.

View Press Kits

Media Contacts

United States, Canada, and Latin America
+1 212.733.1226

Europe, Middle East, and Africa
+44-(0)845.300.8033

Asia Pacific
+65.918.732.47

Email
[email protected]

Though intended for professional media, these resources may also be interesting to patients, healthcare professionals, and investors. The media relations team is focused on responding to media inquiries. However, we want to ensure that customers, investors, and others receive the appropriate attention.

For patients or healthcare professionals with questions about Pfizer’s vaccines or medicines, please see our global list of medical information contacts.

For investors with questions about Pfizer’s efforts, please visit our contact page and select "Shareholder Services".

For all other non-media inquiries, please visit the contact us page to reach the appropriate Pfizer contact.

Science & Innovation

Biologics vs. Biosimilars: Key Differences Explained

With the potential to offer targeted therapies and reduced side-effects, the drive towards biologics is exciting.

biologic_vs_biosimilar_785x440.jpg
Science & Innovation

Zinc Finger Transcription Factors: The On/Off Switch for Genes Inspired by Frogs

Zinc finger transcription technology could be the on/off switch for mutated genes, opening the door to improved ALS treatment.
Zinc_fingers_Frog_785X440.jpg
Science & Innovation

Making the COVID-19 Oral Treatment: How 2,000+ Pfizer Team Members Made It Happen

As the potential threat of COVID-19 became clear by early 2020, teams across Pfizer sprang into action. Together, they worked to better understand the novel virus.

Making the COVID-19 Oral Treatment